CN Patent

CN105431145B — 用于呋塞米的皮下施用的药物制剂

Assigned to ScPharmaceuticals Inc · Expires 2019-12-10 · 6y expired

What this patent protects

本教导涉及呋塞米的液体药物制剂，其中所述药物制剂包括摩尔过量的三(羟甲基)氨基甲烷比呋塞米，具有7至8.5的pH值，和大于或等于约50mM的三(羟甲基)氨基甲烷的浓度。本教导可提高包含呋塞米的液体药物制剂的稳定性和该种药物制剂用于皮下施用或递送的适用性。

USPTO Abstract

本教导涉及呋塞米的液体药物制剂，其中所述药物制剂包括摩尔过量的三(羟甲基)氨基甲烷比呋塞米，具有7至8.5的pH值，和大于或等于约50mM的三(羟甲基)氨基甲烷的浓度。本教导可提高包含呋塞米的液体药物制剂的稳定性和该种药物制剂用于皮下施用或递送的适用性。

Drugs covered by this patent

Patent Metadata

Patent number
CN105431145B
Jurisdiction
CN
Classification
—
Expires
2019-12-10
Drug substance claim
No
Drug product claim
No
Assignee
ScPharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.